Ace Blend funding has reached $9.9 million in a round led by 3one4 Capital, with existing investor Fireside Ventures also participating. The Bengaluru-based nutrition brand plans to use the capital for research and product development.
The company is developing new nutrition formats, which it expects to launch in the January-March quarter of 2027. Ace Blend said it holds patents for these formats.
The company has not disclosed its valuation or the individual contributions of investors in the latest funding round.
Ace Blend plans new nutrition product launches in 2027
Ace Blend will direct the fresh capital towards research, product innovation and the development of new nutrition formats.
The company said it controls ingredient sourcing, formulation and manufacturing. It also uses accredited laboratories in Europe for independent clinical validation and automated testing.
“That foundation gives the company control over quality and claims, more depth to innovate, and an efficiency advantage that is difficult to reproduce,” said Pranav Pai, managing partner at 3one4 Capital.
Ace Blend also said it has secured exclusive rights in India to certain technologies developed by ingredient suppliers DSM and TCI.
Fireside Ventures backs Ace Blend again
Founded by Shivam Hingorani, Ace Blend recorded its first sales in 2018. Saif Mehkri, who has nearly three decades of experience in the nutrition industry, joined the company as co-founder in 2022.
Its product portfolio includes supplements targeting heart health, immunity, sleep, recovery and brain health.
The company said more than 46 per cent of its customers return to make another purchase.
Fireside Ventures had previously led Ace Blend’s $3.3 million pre-Series A funding round. Its participation in the latest round marks another investment in the nutrition brand.
